Therapax Dxt 300 Model HF-300
System, Therapeutic, X-Ray. 510(k) K973315, from Pantak, Inc. (Branford, CT). Product code JAD, class 2.
As of Nov 21, 2026, K973315 is an FDA 510(k) held by Pantak, Inc., substantially equivalent on Dec 2, 1997 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
The Therapax DXT 300 is a variable high energy X-Ray system intended for superficial to subcutaneous radiotherapy treatments of cancerous tumours and lesions. Typical applications include treatment for basal and squamous cell carcinoma, cancerous lung, breast, ribs, rectal adenocarcinoma and other intracavital sites.
- GentleBeam (GB1000)K250692 · Voxel Ray Solutions, LLC · Dec 3, 2025
- INTRABEAM (700); And accessories (INTRABEAM SMART Stand, INTRABEAM SMART Spherical Applicator, INTRABEAM Spherical…K241174 · Carl Zeiss Meditec, AG · Jan 10, 2025
- X80 / RADiant / PhotoElectric Therapy System (RADiant Aura)K230611 · Xstrahl, Ltd. · Jul 13, 2023
- EsteyaK213942 · Nucletron B.V. · Jan 11, 2022
- Type
- Traditional
- Received
- Sep 3, 1997
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5900
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files